Table 3 Univariate and multivariate predictors of hepatic failure

Age (year)

0.999(0.97–1.03)

0.998

 Male

1

1

 Female

0.443(0.21–0.95)

0.037

0.572(0.17–1.94)

 0.371

 DM

0.868(0.35–2.15)

0.760

 HT

0.468(0.21–1.06)

0.069

 DLP

0.227(0.05–0.96)

0.044

0.634(0.13–3.16)

0.579

 HBV

1.139(0.50–2.58)

0.756

 HCV

0.754(0.18–3.22)

0.703

 No

1

1

 Yes

2.714(1.28–5.72)

0.009

1.822(0.57–5.80)

0.310

 No

1

 Yes

1.564(0.66–3.70)

0.309

 Benign

1

 Malignant

1.976(0.90–4.34)

0.090

ICG R15, n = 537

1.032(1.00–1.06)

0.031

1.091(1.03–1.15)

0.002

 Minor

1

1

 Major

12.481(5.05–30.83)

0.000

5.964(1.70–20.96)

0.005

Operative time (h), n = 877

1.568(1.37–1.79)

0.000

Blood loss (ml), n = 877

1.032(1.02–1.05)

0.000

1.019(1.00–1.04)

0.049

Clamp time (min), n = 620

1.013(1.00–1.02)

0.014

Pre-op creatinine (mg/dL), n = 796

0.691(0.21–2.32)

0.550

 ALBI grade I (≤− 2.60)

1

 ALBI grade II (> − 2.60 to ≤ − 1.39)

0.248(0.03–2.07)

0.198

 ALBI grade 3 (> − 1.39)

0.747(0.09–6.21)

0.788

Pre-op platelet, n = 830

1.078(0.72–1.61)

0.711

 TB (mg/dL) day 1, n = 797

1.062(1.01–1.12)

0.019

 ALP (U/L) day 1, n = 797

3.036(1.93–4.78)

0.000

 Alb (g/L) day 1, n = 825

0.995(0.91–1.09)

0.916

 INR day 1, n = 768

2.645(2.04–3.42)

0.000

2.025(1.36–3.00)

0.000

 ALT ≤ 270

1

 ALT > 270

6.539(2.78–15.38)

0.000

 AST ≤ 260

1

1

 AST > 260

13.980(4.20–46.49)

0.000

5.346(1.37–20.83)

0.016